by Setu Dambhare | Mar 27, 2024 | Uncategorized
Meet Mantis’ team: our first employee, Ingrid Amer Cid Last but not least of this serie of meeting Mantis’ team: our remarkable first employee. Thank you for following us through this journey, we will come back once the team grows. Can you talk a bit about...
by Setu Dambhare | Mar 18, 2024 | Uncategorized
Our CEO Denis on the Road in the UK: Learning How the NHS Aims to Benefit from the Eye as the Window to Your Health A month ago, Mantis Photonics’ CEO, Denis Hellebuyck, joined a Nordic Healthy Ageing Delegation on a journey to the UK, connecting with healthcare...
by Setu Dambhare | Feb 29, 2024 | Uncategorized
Choroidal Naevi Breakthrough: Navigating Success with Hyperspectral Imaging Studies Choroidal Naevi are pigmented lesions observed beneath the retina, in the choroid region of the eye, similar to the pigment spots you can see on your skin. While less common than their...
by Diego Guenot | Jan 26, 2024 | Uncategorized
What is the potential of hyperspectral retinal imaging? In 2016, Google has published a deep learning algorithm to detect diabetic retinopathy (DR) called Automated Retinal Disease Assessment (ARDA)¹. The model trained on more than 100,000 retinal images was able to...
by Diego Guenot | Jan 26, 2024 | Uncategorized
Webinar’s Q&A Mantis Photonics conducted a webinar on January 11th 2024, aiming to introduce the company to potential investors. Following the meeting, a question and answer (Q&A) session occurred, you can find the transcription directly below. For...
by Diego Guenot | Jan 26, 2024 | Uncategorized
Mantis Photonics’ crowdfunding campaign gaining momentum Mantis Photonics, a Swedish medical technology company developing non-invasive and portable hyperspectral imaging solutions for early disease detection, has surpassed the 50% funding milestone in its...
